- PLN372.32m
- PLN315.66m
Brief: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Brief: Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility
Brief: Bioceltix Q3 Net Loss At 4.4 Mln Zlotys
Brief: TFI PZU Funds Up Stake In Bioceltix To 15.75%
Brief: Bioceltix Says EGM To Vote On Increase of Share Capital Via Issue Of O Series Shares
Brief: Bioceltix Says Alternative Solution And Kvarko Group Cut Stakes In Company
Brief: Bioceltix's Shareholders Complete ABB Process
Brief: Bioceltix Shareholders Start ABB For Sale Of Up To 577,785 Company Shares
Brief: Bioceltix Plans To Increase Capital To Partially Finance New Stem Cell Facility
Brief: Bioceltix Signs Annex To Project Work Deal With Bionexen
Brief: Bioceltix Reports Positive Final Trial Results For Dog Drug
Financing Deal For New Pharmaceutical Plant
Brief: Bioceltix Q1 Net Loss At 3.8 Mln Zlotys
Brief: Bioceltix Submits Application To EMA For BCX-EM Marketing Authorization
Brief: Bioceltix Pharmaceutical Plant Project Receives Approval From Poland's Enterprise Development Agency
Brief: Bioceltix Sets Price For K Series Shares Under ABB At 37 Zlotys/SHR
Brief: Bioceltix Signs Investment Deal With Kvarko Group